Literature DB >> 28389591

CD11c-Expressing Cells Affect Regulatory T Cell Behavior in the Meninges during Central Nervous System Infection.

Carleigh A O'Brien1, Christopher Overall1, Christoph Konradt2, Aisling C O'Hara Hall2, Nikolas W Hayes1, Sagie Wagage2, Beena John2, David A Christian2, Christopher A Hunter2, Tajie H Harris3.   

Abstract

Regulatory T cells (Tregs) play an important role in the CNS during multiple infections, as well as autoimmune inflammation, but the behavior of this cell type in the CNS has not been explored. In mice, infection with Toxoplasma gondii leads to a Th1-polarized parasite-specific effector T cell response in the brain. Similarly, Tregs in the CNS during T. gondii infection are Th1 polarized, as exemplified by their T-bet, CXCR3, and IFN-γ expression. Unlike effector CD4+ T cells, an MHC class II tetramer reagent specific for T. gondii did not recognize Tregs isolated from the CNS. Likewise, TCR sequencing revealed minimal overlap in TCR sequence between effector T cells and Tregs in the CNS. Whereas effector T cells are found in the brain parenchyma where parasites are present, Tregs were restricted to the meninges and perivascular spaces. The use of intravital imaging revealed that activated CD4+ T cells within the meninges were highly migratory, whereas Tregs moved more slowly and were found in close association with CD11c+ cells. To test whether the behavior of Tregs in the meninges is influenced by interactions with CD11c+ cells, mice were treated with anti-LFA-1 Abs to reduce the number of CD11c+ cells in this space. The anti-LFA-1 treatment led to fewer contacts between Tregs and the remaining CD11c+ cells and increased the speed of Treg migration. These data suggest that Tregs are anatomically restricted within the CNS, and their interaction with CD11c+ populations regulates their local behavior during T. gondii infection.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28389591      PMCID: PMC5451665          DOI: 10.4049/jimmunol.1601581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

Review 2.  Regulatory T cells in the central nervous system.

Authors:  Daniel E Lowther; David A Hafler
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.

Authors:  Marcus Müller; Sally L Carter; Markus J Hofer; Peter Manders; Daniel R Getts; Meghan T Getts; Angela Dreykluft; Bao Lu; Craig Gerard; Nicholas J C King; Iain L Campbell
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

4.  Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.

Authors:  Kaifeng Lisa Lin; LeShara M Fulton; Matthew Berginski; Michelle L West; Nicholas A Taylor; Timothy P Moran; James M Coghill; Bruce R Blazar; James E Bear; Jonathan S Serody
Journal:  Blood       Date:  2014-01-10       Impact factor: 22.113

5.  Discrete TCR repertoires and CDR3 features distinguish effector and Foxp3+ regulatory T lymphocytes in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis.

Authors:  Phuong Nguyen; Wei Liu; Jing Ma; Jean N Manirarora; Xin Liu; Cheng Cheng; Terrence L Geiger
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

6.  In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.

Authors:  Joji Fujisaki; Juwell Wu; Alicia L Carlson; Lev Silberstein; Prabhakar Putheti; Rafael Larocca; Wenda Gao; Toshiki I Saito; Cristina Lo Celso; Hitoshi Tsuyuzaki; Tatsuyuki Sato; Daniel Côté; Megan Sykes; Terry B Strom; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

7.  Regulatory T cells in central nervous system injury: a double-edged sword.

Authors:  James T Walsh; Jingjing Zheng; Igor Smirnov; Ulrike Lorenz; Kenneth Tung; Jonathan Kipnis
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

8.  Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis.

Authors:  Beena John; Brendon Ricart; Elia D Tait Wojno; Tajie H Harris; Louise M Randall; David A Christian; Beth Gregg; Daniel Manzoni De Almeida; Wolfgang Weninger; Daniel A Hammer; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2011-09-15       Impact factor: 6.823

9.  Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii.

Authors:  Beena John; Tajie H Harris; Elia D Tait; Emma H Wilson; Beth Gregg; Lai Guan Ng; Paulus Mrass; David S Roos; Florence Dzierszinski; Wolfgang Weninger; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

10.  Dynamics of the meningeal CD4(+) T-cell repertoire are defined by the cervical lymph nodes and facilitate cognitive task performance in mice.

Authors:  A Radjavi; I Smirnov; N Derecki; J Kipnis
Journal:  Mol Psychiatry       Date:  2013-06-11       Impact factor: 15.992

View more
  10 in total

1.  IL-10 and ICOS Differentially Regulate T Cell Responses in the Brain during Chronic Toxoplasma gondii Infection.

Authors:  Carleigh A O'Brien; Samantha J Batista; Katherine M Still; Tajie H Harris
Journal:  J Immunol       Date:  2019-02-04       Impact factor: 5.422

Review 2.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

Review 3.  Moving to the Outskirts: Interplay Between Regulatory T Cells and Peripheral Tissues.

Authors:  Anna Estrada Brull; Camilla Panetti; Nicole Joller
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 4.  Meningeal Lymphatics: From Anatomy to Central Nervous System Immune Surveillance.

Authors:  Zachary Papadopoulos; Jasmin Herz; Jonathan Kipnis
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

5.  Robust Control of a Brain-Persisting Parasite through MHC I Presentation by Infected Neurons.

Authors:  Anna Salvioni; Marcy Belloy; Aurore Lebourg; Emilie Bassot; Vincent Cantaloube-Ferrieu; Virginie Vasseur; Sophie Blanié; Roland S Liblau; Elsa Suberbielle; Ellen A Robey; Nicolas Blanchard
Journal:  Cell Rep       Date:  2019-06-11       Impact factor: 9.423

Review 6.  Protective and Pathological Immunity during Central Nervous System Infections.

Authors:  Robyn S Klein; Christopher A Hunter
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

7.  The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival.

Authors:  Shraddha Tuladhar; Joshua A Kochanowsky; Apoorva Bhaskara; Yarah Ghotmi; Sambamurthy Chandrasekaran; Anita A Koshy
Journal:  PLoS Pathog       Date:  2019-10-24       Impact factor: 6.823

Review 8.  Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology.

Authors:  Darya Malko; Tarek Elmzzahi; Marc Beyer
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

9.  Streptococcus pneumoniae Rapidly Translocate from the Nasopharynx through the Cribriform Plate to Invade the Outer Meninges.

Authors:  Stavros Panagiotou; Shadia Khandaker; Aras Kadioglu; Marie Yang; Teerawit Audshasai; Jonathan A Coles; Hannah E Scales; Morten Kjos; Murielle Baltazar; Julie Vignau; James M Brewer
Journal:  mBio       Date:  2022-08-04       Impact factor: 7.786

10.  ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain.

Authors:  Carleigh A O'Brien; Tajie H Harris
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.